House Republicans Push Rescheduling Block Despite Trump's Support

House Republicans are moving forward with legislation to prevent marijuana rescheduling, setting up a potential clash with the Trump administration just days after the White House signaled its support for the reform.

The House Appropriations Subcommittee on Commerce, Justice, Science, and Related Agencies released text Wednesday of a funding bill that includes language blocking the Drug Enforcement Administration from using federal funds to reschedule cannabis. The rider represents a direct challenge to the administration's stated position on the issue.

The timing puts congressional Republicans at odds with their own party's president. Last week, the Trump administration announced it would proceed with moving marijuana from Schedule I to Schedule III under the Controlled Substances Act—a reform initiated during the Biden administration but now embraced by Trump officials.

The Legislative Maneuver

The appropriations rider works by prohibiting the Justice Department and DEA from spending any allocated funds on rescheduling activities. It's a tactic Republicans have employed before on various policy issues, using the power of the purse to block executive branch actions.

Similar language appeared in previous appropriations proposals but failed to make it into final spending packages. This year's version comes as the rescheduling process has advanced further than ever before, with DEA hearings scheduled and the administration publicly committed to the change.

Policy experts suggest the move reflects ongoing divisions within the Republican party over cannabis reform. While Trump has signaled openness to rescheduling and many GOP voters support legalization, traditional drug war hawks in Congress remain influential on appropriations committees.

Industry Implications

The cannabis industry has been anticipating rescheduling as a major regulatory shift that would provide significant tax relief. Under current Schedule I classification, businesses cannot deduct normal operating expenses under IRS code 280E—a provision that creates effective tax rates exceeding 70% for many operators.

Rescheduling to Schedule III would eliminate the 280E burden, potentially saving the industry hundreds of millions of dollars annually. Major multi-state operators have factored this tax relief into their financial projections and growth plans.

But the congressional action introduces new uncertainty. Even if the appropriations rider doesn't ultimately pass, it signals that rescheduling faces continued opposition from key lawmakers who control federal spending.

What Happens Next

The subcommittee bill must still pass the full Appropriations Committee, then the House floor, and eventually be reconciled with Senate versions before becoming law. Democrats control the Senate and are unlikely to accept the rescheduling block, setting up potential negotiations.

The DEA has scheduled administrative hearings on rescheduling for later this year, with the process expected to conclude in 2025. The agency would need funding to complete that process—exactly what the Republican rider aims to prevent.

Meanwhile, the Trump administration hasn't publicly responded to the congressional effort to block its stated policy. Whether the White House will pressure House Republicans to drop the provision remains unclear.

The disconnect between Trump's position and congressional Republican action reflects the complex politics of cannabis reform. While public opinion has shifted dramatically in favor of legalization, institutional resistance persists in key congressional committees where longtime drug war supporters maintain influence over the appropriations process.

---

This article is based on original reporting by www.marijuanamoment.net.